SCHEMBL7102472

SCHEMBL7102472

Cc1c(O)cccc1C(C)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.47
PTGS1 P23219 6/20 0.47
CXCL8 P10145 2/20 0.45
TRPA1 O75762 1/20 0.45
ATM Q13315 1/20 0.45
GABRA1 P14867 2/20 0.43
GABRB2 P47870 2/20 0.43
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
MMP14 P50281 1/20 0.41
MMP16 P51512 1/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28818939 0.86 TRPA1 (0.46) PTGS2PTGS1TRPA1ATMGABRA1
SCHEMBL490576 0.84 PTGS2 (0.47) PTGS2PTGS1CXCL8TRPA1GABRA1
SCHEMBL153695 0.83 PTGS2 (0.59) PTGS2PTGS1CXCL8GABRA1GABRB2
Acetic Acid SCHEMBL3429078 0.82 GABRA1 (0.52) PTGS1TRPA1ATMGABRA1GABRB2
SCHEMBL3083070 0.82 TRPA1 (0.43) PTGS1TRPA1ATMGABRA1GABRB2
SCHEMBL2035096 0.82 CXCL8 (0.46) PTGS2PTGS1CXCL8TRPA1ATM
Methane SCHEMBL17958768 0.82 PTGS2 (0.57) PTGS2PTGS1CXCL8GABRA1GABRB2
SCHEMBL2731013 0.82 PTGS2 (0.57) PTGS2PTGS1CXCL8GABRA1GABRB2
SCHEMBL60358 0.82 PTGS2 (0.49) PTGS2PTGS1CXCL8TRPA1MMP1
SCHEMBL4070595 0.81 ADRA2B (0.47) PTGS2PTGS1CXCL8GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011161646-A2 PROCESS FOR THE PREPARATION OF ALVIMOPAN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF RANBAXY LABORATORIES LIMITED (IN) 2011-12-29 WO claimed
WO-2011161646-A2 PROCESS FOR THE PREPARATION OF ALVIMOPAN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF RANBAXY LABORATORIES LIMITED (IN) 2011-12-29 WO disclosed
EP-0503563-B1 Novel 8-substituted purines as selective adenosine receptor agents MERRELL PHARMA INC (US) 2003-09-17 EP disclosed
US-5208240-A Alzeheimer's, cardiovascular, respiratory MERRELL DOW PHARMACEUTICALS INC. (US) 1993-05-04 US disclosed
EP-0503563-A2 Novel 8-substituted purines as selective adenosine receptor agents MERRELL PHARMACEUTICALS INC. (US) 1992-09-16 EP disclosed